Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B

NCT06636175 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06636175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06636175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
March 20, 2025
Completion date
August 28, 2026
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, follicular lymphoma, low-grade lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma, multiple myeloma, small lymphocytic lymphoma